Literature DB >> 28394920

Retraction: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells.

.   

Abstract

Entities:  

Year:  2017        PMID: 28394920      PMCID: PMC5386286          DOI: 10.1371/journal.pone.0175869

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The authors Min-Jean Yin and Rounak Nassirpour and a Pfizer representative contacted the editorial office to raise that there are image duplications in Figure 4B of this article. Pfizer has undertaken a review and deemed that important conclusions in the manuscript cannot be verified, as original images cannot be located. In light of the concerns identified, the authors and the PLOS ONE Editors retract this article. We did not receive any response or comment from Pramod Mehta.
  1 in total

1.  miR-221 promotes tumorigenesis in human triple negative breast cancer cells.

Authors:  Rounak Nassirpour; Pramod P Mehta; Sangita M Baxi; Min-Jean Yin
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

  1 in total
  2 in total

1.  miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF.

Authors:  Xinping Xie; Yuxiu Huang; Lihong Chen; Jinhua Wang
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

2.  Estrogen Abolishes the Repression Role of gga-miR-221-5p Targeting ELOVL6 and SQLE to Promote Lipid Synthesis in Chicken Liver.

Authors:  Ding-Ding Zhang; Dan-Dan Wang; Zhang Wang; Yang-Bin Wang; Guo-Xi Li; Gui-Rong Sun; Ya-Dong Tian; Rui-Li Han; Zhuan-Jian Li; Rui-Rui Jiang; Xiao-Jun Liu; Xiang-Tao Kang; Hong Li
Journal:  Int J Mol Sci       Date:  2020-02-27       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.